Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1988
v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancerM Mabry, T Nakagawa, B D Nelkin, et al.
Cancer Research|August 1, 1989
Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinomaB D Nelkin, Y Nakamura, R W White, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 1997
Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expressionH Chen, A Thiagalingam, H Chopra, et al.
Cancer Research|August 4, 2006
Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cellsChristopher J Strock, Jong-In Park, Eric K Nakakura, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1991
High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancerW S el-Deiry, B D Nelkin, P Celano, et al.
Journal of the National Cancer Institute|August 4, 1993
Increased cytosine DNA-methyltransferase activity during colon cancer progressionJ P Issa, P M Vertino, J Wu, et al.
Molecular Cancer Therapeutics|May 2, 2015
Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft ModelsChaoxin Hu, Tikva Dadon, Venugopal Chenna, et al.
Cancer Research|January 30, 2009
Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancerTianyun Jiang, Brendan J Collins, Ning Jin, et al.
The Journal of Clinical Investigation|June 1, 1990
v-rasH induces non-small cell phenotype, with associated growth factors and receptors, in a small cell lung cancer cell lineJ P Falco, S B Baylin, R Lupu, et al.
Cancer Research|May 21, 2010
Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signalingGeorg Feldmann, Anjali Mishra, Seung-Mo Hong, et al.
Pageof 12